(3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin

更新时间：2025-09-21 09:12:08

(3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin结构式	常用名	(3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin	英文名	(3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin
	CAS号	162869-75-2	分子量	298.37
	密度	N/A	沸点	N/A
	分子式	C₁₆H₂₆O₅	熔点	N/A
	MSDS	N/A	闪点	N/A

英文名	(3R,5aS,6R,8aS,9S,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin

分子式	C₁₆H₂₆O₅
分子量	298.37
InChIKey	SXYIRMFQILZOAM-CVRZQRFUSA-N
SMILES	COC1OC2OC3(C)CCC4C(C)CCC(C1C)C24OO3

实验名称：insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen
来源：846
靶标：N/A
External Id：5mMGluc_INS1E_InsulinRelease_40mMGluc_SP

实验名称：HT-29 viability from Cell TiterGlo-IC50
来源：846
靶标：N/A
External Id：Basal_Viability_ATP_HT-29_CRC

实验名称：HCT116 viability from Cell TiterGlo-IC50
来源：846
靶标：N/A
External Id：Basal_Viability_ATP_HCT116_CRC

实验名称：Colo320 viability from Cell TiterGlo-IC50
来源：846
靶标：N/A
External Id：Basal_Viability_ATP_Colo_320_CRC

实验名称：VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50
来源：846
靶标：N/A
External Id：VEGF_ADSC_ECFC_Angio_CD31_TubeArea_CRC

实验名称：GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen
来源：846
靶标：N/A
External Id：GSK3b_inh_pretreated_Viability_ATP_HCT116_SP

实验名称：GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50
来源：846
靶标：N/A
External Id：GSK3b_inh_pretreated_Viability_ATP_HCT116_CRC

实验名称：SW480 viability from Cell TiterGlo-IC50
来源：846
靶标：N/A
External Id：Basal_Viability_ATP_SW480_CRC

实验名称：Cytotoxicity counterscreen for inhibitors of SARS-CoV-2 cell entry
来源：NCGC
靶标：N/A
External Id：TRND-SARS-CoV-2-cytotox-48hr

实验名称：GLP1 secretion from NCI-H716 cells-screen
来源：846
靶标：N/A
External Id：hNCI-H716_GLP1_Secretion_SP

共25条，当前第1页，共3页

名称